For: | Bergantin LB. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signaling. World J Diabetes 2021; 12(6): 767-779 [PMID: 34168726 DOI: 10.4239/wjd.v12.i6.767] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i6/767.htm |
Number | Citing Articles |
1 |
Asim K. Duttaroy, Rahul Mallick. Cellular, Molecular, and Environmental Contribution in Cardiac Remodeling. 2024; : 171 doi: 10.1016/B978-0-323-99570-2.00009-6
|
2 |
Leandro Bueno Bergantin. Ca2+/cAMP Ratio as an Inflammatory Index. Current Hypertension Reviews 2023; 19(1): 4 doi: 10.2174/1573402119666221202145753
|
3 |
Chunxiao Liu, Hui Wang, Lu Han, Yifan Zhu, Shurui Ni, Jingke Zhi, Xiping Yang, Jiayi Zhi, Tian Sheng, Huanqiu Li, Qinghua Hu. Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-46365-x
|
4 |
Md Al-Mustanjid, S. M. Hasan Mahmud, Farzana Akter, Md Shazzadur Rahman, Md Sajid Hossen, Md Habibur Rahman, Mohammad Ali Moni. Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases. Informatics in Medicine Unlocked 2022; 32: 101003 doi: 10.1016/j.imu.2022.101003
|
5 |
Santosh K Sanganalmath, Shubham Dubey, Sudhakar Veeranki, Keerthy Narisetty, Prasanna Krishnamurthy. The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy. Cardiovascular Diabetology 2023; 22(1) doi: 10.1186/s12933-023-01755-1
|
6 |
Leandro Bueno Bergantin. COVID-19 and Obesity: Reevaluating the Relationship Through
Ca2+/cAMP Signalling. Current Drug Research Reviews 2022; 14(3): 157 doi: 10.2174/1573399818666220429100819
|
7 |
Leandro Bueno Bergantin. The Connections between Inflammaging and Ca2+/cAMP Signalling: A Unified Theory. Current Topics in Medicinal Chemistry 2024; 24(16): 1359 doi: 10.2174/0115680266308671240514063347
|
8 |
O.I. Kit, E.M. Frantsiyants, V.A. Bandovkina, I.V. Neskubina, A.I. Shikhlyarova, I.V. Kaplieva, E.I. Surikova, Y.A. Pogorelova, N.D. Cheryarina, L.K. Trepitaki, I.A. Goroshinskaya, L.N. Vaschenko, Y.S. Shatova, L.P. Kuchkina, V.A. Kovalenko, L.A. Nemashkalova. cAMP сoncentrations in cardiac mitochondria and serum in the С57ВL/6 mice under independent melanoma В16/F10 growth versus melanoma В16/F10 growth linked to chronic neurogenic pain. CARDIOMETRY 2022; (22): 62 doi: 10.18137/cardiometry.2022.22.6268
|
9 |
Leandro B. Bergantin. A Timeline of Ca2+/cAMP Signalling: From Basic Research to Potential
Therapeutics for Dementia. Current Alzheimer Research 2022; 19(3): 179 doi: 10.2174/1567205019666220415125447
|
10 |
Leandro Bueno Bergantin. Mental Disorders and Poor COVID-19 Prognosis: Reevaluating the Relationship
through Ca2+/cAMP Signalling. Current Topics in Medicinal Chemistry 2022; 22(15): 1215 doi: 10.2174/1568026622666220504163811
|
11 |
Leandro Bueno Bergantin. The Connections between Atrial Fibrillation and Mental Disorders: Role
of Ca2+/cAMP Signalling. Current Signal Transduction Therapy 2024; 19(3) doi: 10.2174/0115743624316217240520113601
|
12 |
Leandro Bergantin. Ca<sup>2+</sup>/cAMP ratio: An inflammatory index for diabetes, hypertension, and COVID-19. World Journal of Diabetes 2023; 14(3): 343-346 doi: 10.4239/wjd.v14.i3.343
|
13 |
Leandro Bueno Bergantin. Ca2+/cAMP ratio in age-related diseases. Brain Circulation 2024; 10(3): 281 doi: 10.4103/bc.bc_3_24
|
14 |
Leandro Bueno Bergantin. Neuroinflammation, Diabetes and COVID-19: Perspectives Coming from
Ca2+/cAMP Signalling. Current Drug Research Reviews 2022; 14(1): 6 doi: 10.2174/2589977514666211231141401
|
15 |
Thayse Evellyn Silva do Nascimento, Jorge A. López, Eder Alves Barbosa, Marcela Abbott Galvão Ururahy, Adriana da Silva Brito, Gabriel Araujo-Silva, Jefferson Romáryo Duarte da Luz, Maria das Graças Almeida. Mass Spectrometric Identification of Licania rigida Benth Leaf Extracts and Evaluation of Their Therapeutic Effects on Lipopolysaccharide-Induced Inflammatory Response. Molecules 2022; 27(19): 6291 doi: 10.3390/molecules27196291
|
16 |
Mingyang Sun, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang. Dose-Dependent Effect of Aspirin Use in Reducing Diabetes-Associated Dementia Risk Among Elderly Patients With Type 2 Diabetes Mellitus. Journal of the American Medical Directors Association 2024; 25(5): 889 doi: 10.1016/j.jamda.2024.03.110
|
17 |
Na Liu, Xin Cui, Wenhui Yan, Tingli Guo, Zhuanzhuan Wang, Xiaotong Wei, Yuzhuo Sun, Jieyun Liu, Cheng Xian, Weina Ma, Lina Chen. Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement. Journal of Pharmaceutical Analysis 2024; 14(8): 100968 doi: 10.1016/j.jpha.2024.100968
|
18 |
Shreya Sood, Sushma Devi, Thakur Gurjeet Singh, Randhir Singh. Targeting Insulin- and Calcium-related Pathways for Potential Treatments
for Alzheimer's Disease and Diabetes. Current Signal Transduction Therapy 2024; 19(3) doi: 10.2174/0115743624299306240419054021
|
19 |
Leandro Bueno Bergantin. The Interactions among Hypertension, Cancer, and COVID-19: Perspective with Regard to Ca2+/cAMP Signalling. Current Cancer Drug Targets 2022; 22(5): 351 doi: 10.2174/1568009622666220215143805
|